Efficacy and safety of Argatroban in patients with acute ischemic stroke: a systematic review and meta-analysis
ObjectiveArgatroban is a highly promising drug for the treatment of acute ischemic stroke (AIS), but there is currently insufficient strong evidence regarding the efficacy and safety of using Argatroban in the treatment of AIS. Therefore, we conducted a systematic review and meta-analysis to evaluat...
Main Authors: | YiRan Cheng, ChangNing Liu, ShanShan Li, Miao Miao Meng, He Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1364895/full |
Similar Items
-
The effect of argatroban on early neurological deterioration and outcomes in minor ischemic stroke: preliminary findings
by: Xuehong Jin, et al.
Published: (2024-03-01) -
Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis
by: Xiao‐Qiu Li, et al.
Published: (2022-07-01) -
Early argatroban and antiplatelet combination therapy in acute non-lacunar single subcortical infarct associated with mild intracranial atherosclerosis
by: Peng-Fei Wang, et al.
Published: (2021-11-01) -
Malnutrition and the Risk of Early Neurological Deterioration in Elderly Patients with Acute Ischemic Stroke
by: Bao Y, et al.
Published: (2022-08-01) -
Predictive values of systemic inflammatory responses index in early neurological deterioration in patients with acute ischemic stroke
by: Jia Wang, et al.
Published: (2022-05-01)